Section Arrow
CYTK.NASDAQ
- Cytokinetics
Quotes are at least 15-min delayed:2025/11/16 11:05 EST
Regular Hours
Last
 66.44
+0.92 (+1.40%)
Day High 
67.07 
Prev. Close
65.52 
1-M High
66.98 
Volume 
2.15M 
Bid
66.3
Ask
67.5
Day Low
64.11 
Open
64.11 
1-M Low
54.3 
Market Cap 
8.01B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 62.31 
20-SMA 60.76 
50-SMA 56.77 
52-W High 66.98 
52-W Low 29.31 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.30/-5.85
Enterprise Value
8.77B
Balance Sheet
Book Value Per Share
-4.26
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
18.47M
Operating Revenue Per Share
0.06
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed:2025/11/16 11:05 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.